Alterity Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.16M Sell
7,378
-271
-4% -$41.6K 1.65% 18
2023
Q3
$1.19M Sell
7,649
-144
-2% -$23.8K 1.89% 14
2023
Q2
$1.29M Sell
7,793
-3,572
-31% -$577K 1.86% 17
2023
Q1
$1.76M Sell
11,365
-118
-1% -$19.1K 2.58% 10
2022
Q4
$2.03M Sell
11,483
-57
-0.5% -$9.84K 3.29% 5
2022
Q3
$1.89M Sell
11,540
-2,138
-16% -$362K 3.05% 5
2022
Q2
$2.43M Buy
+13,678
New +$2.44M 3.61% 4
2021
Q4
$2.36M Buy
+13,809
New +$2.26M 2.53% 10
2021
Q1
$2.4M Buy
+13,520
New +$2.19M 2.9% 7

Other funds holding JNJ

Alterity Financial Group's JNJ Position: Q4 2023 in Review

Alterity Financial Group reduced its Johnson & Johnson (JNJ) stake by 3.5% in Q4 2023, selling an estimated $41.6K and leaving 7,378 shares worth $1.16M. The position accounts for 1.65% of the portfolio, ranked #18.

Alterity Financial Group first reported a position in JNJ in Q1 2021 and has held it in 9 quarters since. The position peaked at $2.43M in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Alterity Financial Group held 7,378 shares of Johnson & Johnson worth $1.16M as of Q4 2023.
  • Alterity Financial Group sold 271 Johnson & Johnson shares in Q4 2023, an estimated $41.6K.
  • Johnson & Johnson made up 1.65% of Alterity Financial Group's portfolio in Q4 2023, its #18 holding.
  • Alterity Financial Group first reported a position in Johnson & Johnson in Q1 2021 and has held it in 9 quarters since.
  • Alterity Financial Group's Johnson & Johnson position peaked at $2.43M in Q2 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.